Concepedia

Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions

Emmerentia van Schalkwyk, Klara Strydom, Zelda Williams, Louis Venter, Stefan Leichtl, Christine Schmid-Wirlitsch, Dirk Bredenbröker, Philip G. Bardin

Journal of Allergy and Clinical Immunology · 2005 · 109 citations · 16 references

DOI

Concepts

References

16

GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

Romain Pauwels · Arerugī/Arerugi · 1996 · 10.1K citations

, , +10

Standardization of bronchial inhalation challenge procedures

Hyman Chai, Richard S. Farr, Luz A. Froehlich et al. · Journal of Allergy and Clinical Immunology · 1975 · 1.5K citations · Full text

, , +10

Anti-Inflammatory and Immunomodulatory Potential of the Novel PDE4 Inhibitor Roflumilast in Vitro

Armin Hatzelmann, Christian Schudt · Journal of Pharmacology and Experimental Therapeutics · 2001 · 398 citations

, , +10

In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor

Daniela S. Bundschuh, Manfrid Eltze, Johannes Barsig et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 239 citations

, , +16

Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma

Richard Leigh, Dilini Vethanayagam, Makoto Yoshida et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 124 citations

, , +17